How Supplied


NDC No.
00186-
Product
No.
Description Concentration Strength Vial
Size/
Fill
Closure Pack
Size
Min.
Direct
Order
Qty.
0859-81 186085981 SD Infusion
Bottle
2 mg/mL 0.20% 100 mL 28 mm 1 12 x 1
0859-91 186085991 SD Infusion
Bottle
2 mg/mL 0.20% 200 mL 28 mm 1 12 x 1
0859-47 186085944 Polyamp
DuoFit®
Sterile Pak
2 mg/mL 0.20% 10 mL N/A 5 24 x 5
0859-57 186085954 Polyamp
DuoFit®
Sterile Pak
2 mg/mL 0.20% 20 mL N/A 5 20 x 5
0863-57 186086354 Polyamp
DuoFit®
Sterile Pak
5 mg/mL 0.50% 20 mL N/A 5 20 x 5
0863-61 186086361 SD Vial 5 mg/mL 0.50% 30 mL 20 mm 1 50 x 1
0863-61 186086369 Sterile-Pak
SD Vial
5 mg/mL 0.50% 30 mL 20 mm 5 10 x 5
0867-57 186086754 Polyamp
DuoFit®
Sterile Pak
7.5 mg/mL 0.75% 20 mL N/A 5 20 x 5
0868-47 186086844 Polyamp
DuoFit®
Sterile Pak
10 mg/mL 1% 10 mL N/A 5 24 x 5
0868-57 186086854 Polyamp
DuoFit®
Sterile Pak
10 mg/mL 1% 20 mL N/A 5 20 x 5

BAR CODED • LATEX FREE • PRESERVATIVE FREE

Naropin® is a registered trademark of APP Pharmaceuticals, LLC
is a registered trademark of APP Pharmaceuticals, LLC

Polyamp Duofit® is a registered trademark of AstraZeneca AB


Important Safety Information

Using NAROPIN®
beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs.
Like all amide-type local anesthetics, NAROPIN® may be associated with adverse reactions. In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.